- Sector: Healthcare
- Industry: Diagnostics & Research
- Full Time Employees: 145
- Headquarters: Malvern, PA
- Founded: 2003
- http://www.neuronetics.com
Opened for trading at $25 after pricing IPO at $19
Thursday, June 28, 2018
Neuronetics (STIM) began trading on the Nasdaq on 28 June 2018
Neuronetics is a company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology.
Opened for trading at $25 after pricing IPO at $19
Opened for trading at $25 after pricing IPO at $19
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment